test

Login

Forget your password
Creat New account

Home
Excellence in Dyslipidemia
RCR
Newsletters
Events
Contact us
Registration
Login

Welcome to your - test

Your new question! - 2

Your new question!

All of the following are major risk factors for atherosclerotic cardiovascular disease, EXCEPT

Advanced age

Increased total serum cholesterol level

Diabetes and hypertension

Increased LDL

Decreased HDL

Increased VLDL

Residual risk Includes: (Select all that Apply).

A. Inadequate Management of classical risk factors

B. LDL-C Driven Residual risk

C. TG-rich lipoproteins Residual risk

D. Thrombosis Residual risk

E. Inflammation Residual risk

F. All of the above

All of the following are progressive stages of atherosclerosis, EXCEPT

Plaque formation

Plaque disruption

Fatty streak formation

High density lipoprotein

The cholesterol absorption inhibitor ezetimibe can increase the efficacy of which other treatment by 25%?

Statins

Niacin

Fish oil

Fibrates

As per European guidelines dyslipidaemia is defined as

General Population: TC <240 mg/dL and LDL <160 mg/dL; Established ASCVD or DM: TC <175 mg/dL and LDL-C <100 mg/dL

General Population: TC <190 mg/dL and LDL <115 mg/dL; Established ASCVD or DM: TC <175 mg/dL and LDL-C <100 mg/dL

General Population: TC <190 mg/dL and LDL <115 mg/dL; Established ASCVD or DM: TC <175 mg/dL and LDL-C <120 mg/dL

General Population: TC <190 mg/dL and LDL <115 mg/dL; Established ASCVD or DM: TC <175 mg/dL and LDL-C <130 mg/dL

What is the main site of lipid transformation and absorption?

Mouth

Stomach

Small intestine

Large intestine

Which of the following age groups should be screened for dyslipidaemia?

Young adults (men aged 20-45 years; women aged 20-55 years)

Middle-aged adults (men aged 45-65 years; women aged 55-65 years)

Older adults (older than 65 years)

All the above

Time is Up!

Time's up

Please login to download the file

About Us

Algorithm is a regional Pharmaceutical Company operating in the MENA region and committed to improving human health and well-being. As partners to the medical societies and since our aim is to provide patients with updated healthcare practices, we developed this Continuous Medical Education (CME) program to be the core of our dedication towards an enhanced patient care.

Get In Touch

info@dyslipidemiame.com